Hypergiant hepatic hemangiomas: case series

Area of Science:

• Hepatology
• Vascular Biology
• Surgical Oncology

Background:

• Hepatic hemangiomas are common benign liver tumors originating from vascular endothelial cell proliferation.
• Hypergiant hepatic hemangiomas (>10 cm) are rare, and their optimal management remains debated.
• Treatment options for large hepatic hemangiomas vary, including observation, enucleation, and resection.

Purpose of the Study:

• To evaluate the clinical presentation, management, and outcomes of hypergiant hepatic hemangiomas.
• To analyze a series of 10 cases managed over a 5-year period.
• To contribute to the understanding of optimal treatment strategies for these rare tumors.

Main Methods:

• Retrospective review of 10 patients diagnosed with hypergiant hepatic hemangiomas.
• Evaluation of patient demographics, clinical symptoms, diagnostic findings, and treatment modalities.
• Analysis of post-treatment outcomes and follow-up data.

Main Results:

• The series included 10 patients with hypergiant hepatic hemangiomas.
• Surgical intervention was performed in 9 patients (5 resections, 4 enucleations), with one patient managed conservatively.
• All surgically treated patients achieved uneventful recovery, and the conservatively managed patient remained asymptomatic.

Conclusions:

• Surgical management (resection or enucleation) is effective for symptomatic or large hypergiant hepatic hemangiomas.
• Conservative management can be a viable option for asymptomatic cases.
• Hypergiant hepatic hemangiomas, despite their size, can be managed successfully with tailored therapeutic approaches.